Ophthalmic Surg Lasers Imaging Retina. 2024 Jul;55(7):374-382. doi: 10.3928/23258160-20240208-02. Epub 2024 Mar 1.
Our objective was to assess baseline widefield swept-source optical coherence tomography angiography (WF SSOCTA) microvascular metrics as predictors for the number of anti-vascular endothelial growth factor (VEGF) injections and visual acuity (VA) at 12-months follow-up in patients with retinal vein occlusion (RVO).
This was a prospective study including 49 RVO eyes from 49 patients who had not received an anti-VEGF injection for at least 3 months prior to imaging. Microvascular metrics from 6×6-mm and 12×12-mm angiograms were assessed using linear regression models, adjusting for age.
Reductions in the vessel density (VD) and vessel skeletonized density (VSD) vascular metrics were associated both with a higher number of anti-VEGF injections at all follow-up time points and reduced VA 12 months after imaging in all RVO eyes.
WF SS-OCTA VD and VSD micro-vascular metrics at baseline can prognosticate VA and number of anti-VEGF injections required at 3, 6, and 12 months in RVO eyes. .
我们的目的是评估基线宽视野扫频源光相干断层扫描血管造影(WF SSOCTA)微血管指标,作为预测视网膜静脉阻塞(RVO)患者抗血管内皮生长因子(VEGF)注射次数和 12 个月随访时视力(VA)的指标。
这是一项前瞻性研究,纳入了 49 例 RVO 患者的 49 只眼,这些患者在成像前至少 3 个月未接受抗 VEGF 注射。使用线性回归模型评估 6×6mm 和 12×12mm 血管造影的微血管指标,并对年龄进行调整。
在所有随访时间点,血管密度(VD)和血管骨架化密度(VSD)血管指标的降低均与 RVO 眼中抗 VEGF 注射次数的增加以及成像后 12 个月 VA 的降低相关。
WF SS-OCTA 基线时的 VD 和 VSD 微血管指标可以预测 RVO 眼在 3、6 和 12 个月时所需的 VA 和抗 VEGF 注射次数。